Low-dose amphotericin b lipid complex (ablc) is safe and effective as empiric anti-fungal therapy in immunocompromised patients with hematologic malignancies

J. Mehta*, R. Powles, B. Sirohi, J. Treleaven, S. Kulkarni, K. Murphy, A. Conway, C. Cole, R. Saso, S. Singhai

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Low-dose amphotericin b lipid complex (ablc) is safe and effective as empiric anti-fungal therapy in immunocompromised patients with hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds